Abstract:Astrocytes are key players in maintaining central nervous system (CNS) homeostasis. Proper control of cellular bioenergetics is essential for this, and poor control of astrocyte bioenergetics may underlie many CNS conditions. We hypothesized that translocator protein 18 kDa (TSPO) regulates the metabolism of astrocytes and thus serves as a therapeutic target. In two models, TSPO deficiency reduced bioenergetic rates and lactate release, while promoting bioenergetic resistance to glucose withdrawal and fatty acid oxidation (FAO). Following lipopolysaccharide (LPS) stimulation, TSPO deficient astrocytes showed no change in activation of inflammatory pathways but delayed tumor necrosis factor (TNF) release. We think this warrants further investigation into TSPO function in astrocytes, and may present a promising therapeutic target. Schematic created by the authors with https://www.biorender.com. The mitochondrial translocator protein 18 kDa (TSPO) has been linked to functions from steroidogenesis to regulation of cellular metabolism and is an attractive therapeutic target for chronic CNS inflammation. Studies in Leydig cells and microglia indicate that TSPO function may vary between cells depending on their specialized roles. Astrocytes are critical for providing trophic and metabolic support in the brain. Recent work has highlighted that TSPO expression increases in astrocytes under inflamed conditions and may drive astrocyte reactivity. Relatively little is known about the role TSPO plays in regulating astrocyte metabolism and whether this protein is involved in immunometabolic processes in these cells. Using TSPO‐deficient (TSPO−/−) mouse primary astrocytes in vitro (MPAs) and a human astrocytoma cell line (U373 cells), we performed extracellular metabolic flux analyses. We found that TSPO deficiency reduced basal cellular respiration and attenuated the bioenergetic response to glucopenia. Fatty acid oxidation was increased, and lactate production was reduced in TSPO−/− MPAs and U373 cells. Co‐immunoprecipitation studies revealed that TSPO forms a complex with carnitine palmitoyltransferase 1a in U373 and MPAs, presenting a mechanism wherein TSPO may regulate FAO in these cells. Compared to TSPO+/+ cells, in TSPO−/− MPAs we observed attenuated tumor necrosis factor release following 3 h lipopolysaccharide (LPS) stimulation, which was enhanced at 24 h post‐LPS stimulation. Together these data suggest that while TSPO acts as a regulator of metabolic flexibility, TSPO deficiency does not appear to modulate the metabolic response of MPAs to inflammation, at least in response to the model used in this study.

Functional role of translocator protein and its ligands in ocular diseases (Review)

Translocator Protein (18 Kda): A Promising Therapeutic Target and Diagnostic Tool for Cardiovascular Diseases

Roles of TSPO and Its Ligands in Different Neurologic Diseases

Translocator protein (18 kDa) (Tspo) in the retina and implications for ocular diseases

The mitochondrial translocator protein (TSPO) in Alzheimer's disease: Therapeutic and immunomodulatory functions

Deletion of TSPO Causes Dysregulation of Cholesterol Metabolism in Mouse Retina

Translocator protein (18 kDa) (TSPO) ligands activate Nrf2 signaling and attenuate inflammatory responses and oxidative stress in human retinal pigment epithelial cells

Current advances in the structure–activity relationship (SAR) analysis of the old/new 18-kDa translocator protein ligands

Translocator Protein 18 Kda Regulates Retinal Neuron Apoptosis and Pyroptosis in Glaucoma.

Structure-Based Drug Design for TSPO: Challenges and Opportunities

History of Tspo deletion and induction in vivo : Phenotypic outcomes under physiological and pathological situations

Expression, Purification and Characterization of Bacterial and Human Translocator Protein 18 Kda (TSPO)

Diagnostic and Therapeutic Potential of TSPO Studies Regarding Neurodegenerative Diseases, Psychiatric Disorders, Alcohol Use Disorders, Traumatic Brain Injury, and Stroke: An Update

Regulation of astrocyte metabolism by mitochondrial translocator protein 18 kDa

Targeting TSPO Reduces Inflammation and Apoptosis in an In Vitro Photoreceptor-Like Model of Retinal Degeneration

Translocator Protein (TSPO) Role in Aging and Alzheimer’s Disease

Impact of Translocator Protein 18 kDa (TSPO) Deficiency on Mitochondrial Function and the Inflammatory State of Human C20 Microglia Cells

Recent developments on PET radiotracers for TSPO and their applications in neuroimaging

Ro5-4864, a translocator protein ligand, regulates T cell-mediated inflammatory responses in skin

Mitochondrial Translocator Protein (TSPO) Is a Regulator of Fatty Acid Metabolism

The TSPO-NOX1 axis controls phagocyte-triggered pathological angiogenesis in the eye